Compare $ACTU vs $GTBP | Chartloom

Compare

$ACTU vs $GTBP

Actuate Therapeutics Inc · GT Biopharma Inc

ACTU

Actuate Therapeutics Inc

GTBP

GT Biopharma Inc

Compare $ACTU vs $GTBP

Comparing Actuate Therapeutics Inc and GT Biopharma Inc

ACTUActuate Therapeutics Inc

GTBPGT Biopharma Inc

ACTUActuate Therapeutics Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-89.9%

52W performance

-91.3%

FCF yield

-135.8%

GTBPGT Biopharma Inc

Market cap

$296M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-75.3%

FCF yield

-4.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACTU

GTBP

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

GTBP

GT Biopharma Inc

Market Cap

ACTU$15M

GTBP$296M

Enterprise Value

ACTU$11M

GTBP$291M

Price

ACTU$0.61

GTBP$6.68

P/E Ratio

ACTUN/A

GTBPN/A

P/S Ratio

ACTU0.00x

GTBP174.71x

EV/Sales

ACTU0.00x

GTBP95.98x

EV/EBITDA

ACTU0.00x

GTBP0.00x

P/B Ratio

ACTU19.88x

GTBP3.08x

P/FCF Ratio

ACTUN/A

GTBPN/A

EV/FCF

ACTU-0.53x

GTBP-20.19x

PEG Ratio

ACTUN/A

GTBPN/A

Forward P/E (NTM)

ACTUN/A

GTBPN/A

Forward P/S (NTM)

ACTUN/A

GTBPN/A

Revenue (TTM)

ACTU$0

GTBP$0

Revenue Growth (YoY)

ACTUN/A

GTBPN/A

Forward Rev Growth

ACTU50.1%

GTBP216.5%

Gross Margin (TTM)

ACTU0.0%

GTBP36.5%

Operating Margin (TTM)

ACTU0.0%

GTBP0.0%

EBITDA Margin (TTM)

ACTU0.0%

GTBP0.0%

Net Margin (TTM)

ACTU0.0%

GTBP0.0%

FCF Margin (TTM)

ACTUN/A

GTBPN/A

Net Income (TTM)

ACTU$-20M

GTBP$-33M

FCF (TTM)

ACTU$-20M

GTBP$-14M

EPS (TTM)

ACTU-$0.86

GTBP-$21.10

ROE (TTM)

ACTU-34618.0%

GTBP-44308.0%

ROA (TTM)

ACTU-17840.0%

GTBP-31311.0%

ROIC (TTM)

ACTU-32397.0%

GTBP-44308.0%

Cash

ACTU$4M

GTBP$5M

Debt

ACTU$405K

GTBP$0

Net Cash/Debt

ACTU$4M

GTBP$5M

Current Ratio (TTM)

ACTU1.25x

GTBP2.61x

Quick Ratio (TTM)

ACTU1.16x

GTBP2.51x

Debt/Equity (TTM)

ACTU0.41x

GTBP0.00x

Debt/Assets (TTM)

ACTU0.0%

GTBP0.0%

Interest Coverage (TTM)

ACTUN/A

GTBPN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

GTBP0.00x

Beta

ACTU1.66

GTBP0.81

52W Performance

ACTU-91.3%

GTBP-75.3%

YTD Performance

ACTU-89.9%

GTBP-67.3%

% from 52W High

ACTU-92.8%

GTBP-76.8%

% from 52W Low

ACTU1.0%

GTBP36.0%

Asset Turnover (TTM)

ACTU0.00x

GTBP0.08x

FCF Yield (TTM)

ACTU-135.8%

GTBP-4.9%

Earnings Yield (TTM)

ACTU-140.1%

GTBP-11.1%

Dividend Yield (TTM)

ACTUN/A

GTBPN/A

Rule of 40

ACTU0.0

GTBP0.0

EV/GP/RG

ACTUN/A

GTBPN/A

Ticker research

View ACTU research View GTBP research

Metric	ACTU Actuate Therapeutics Inc	GTBP GT Biopharma Inc
Market & Valuation
Market Cap	$15M	$296M
Enterprise Value	$11M	$291M
Price	$0.61	$6.68
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	174.71x
EV/Sales	0.00x	95.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	3.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-20.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	216.5%
Profitability
Gross Margin (TTM)	0.0%	36.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-33M
FCF (TTM)	$-20M	$-14M
EPS (TTM)	-$0.86	-$21.10
ROE (TTM)	-34618.0%	-44308.0%
ROA (TTM)	-17840.0%	-31311.0%
ROIC (TTM)	-32397.0%	-44308.0%
Financial Health
Cash	$4M	$5M
Debt	$405K	$0
Net Cash/Debt	$4M	$5M
Current Ratio (TTM)	1.25x	2.61x
Quick Ratio (TTM)	1.16x	2.51x
Debt/Equity (TTM)	0.41x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.81
52W Performance	-91.3%	-75.3%
YTD Performance	-89.9%	-67.3%
% from 52W High	-92.8%	-76.8%
% from 52W Low	1.0%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.08x
FCF Yield (TTM)	-135.8%	-4.9%
Earnings Yield (TTM)	-140.1%	-11.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View GTBP research

Valuation

P/S Ratio

ACTU

0.00x

GTBP

174.71x

EV/FCF

GTBP

-20.19x

ACTU

-0.53x

Growth & revenue

Forward Revenue Growth

GTBP

216.5%

ACTU

50.1%

Profitability & performance

Gross Margin

GTBP

36.5%

ACTU

0.0%

ROE

ACTU

-34618.0%

GTBP

-44308.0%

FCF Yield %

GTBP

-4.9%

ACTU

-135.8%

52-Week Performance

GTBP

-75.3%

ACTU

-91.3%

Detailed metrics comparison

ACTU

Actuate Therapeutics Inc

GTBP

GT Biopharma Inc

Market Cap

ACTU$15M

GTBP$296M

Enterprise Value

ACTU$11M

GTBP$291M

Price

ACTU$0.61

GTBP$6.68

P/E Ratio

ACTUN/A

GTBPN/A

P/S Ratio

ACTU0.00x

GTBP174.71x

EV/Sales

ACTU0.00x

GTBP95.98x

EV/EBITDA

ACTU0.00x

GTBP0.00x

P/B Ratio

ACTU19.88x

GTBP3.08x

P/FCF Ratio

ACTUN/A

GTBPN/A

EV/FCF

ACTU-0.53x

GTBP-20.19x

PEG Ratio

ACTUN/A

GTBPN/A

Forward P/E (NTM)

ACTUN/A

GTBPN/A

Forward P/S (NTM)

ACTUN/A

GTBPN/A

Revenue (TTM)

ACTU$0

GTBP$0

Revenue Growth (YoY)

ACTUN/A

GTBPN/A

Forward Rev Growth

ACTU50.1%

GTBP216.5%

Gross Margin (TTM)

ACTU0.0%

GTBP36.5%

Operating Margin (TTM)

ACTU0.0%

GTBP0.0%

EBITDA Margin (TTM)

ACTU0.0%

GTBP0.0%

Net Margin (TTM)

ACTU0.0%

GTBP0.0%

FCF Margin (TTM)

ACTUN/A

GTBPN/A

Net Income (TTM)

ACTU$-20M

GTBP$-33M

FCF (TTM)

ACTU$-20M

GTBP$-14M

EPS (TTM)

ACTU-$0.86

GTBP-$21.10

ROE (TTM)

ACTU-34618.0%

GTBP-44308.0%

ROA (TTM)

ACTU-17840.0%

GTBP-31311.0%

ROIC (TTM)

ACTU-32397.0%

GTBP-44308.0%

Cash

ACTU$4M

GTBP$5M

Debt

ACTU$405K

GTBP$0

Net Cash/Debt

ACTU$4M

GTBP$5M

Current Ratio (TTM)

ACTU1.25x

GTBP2.61x

Quick Ratio (TTM)

ACTU1.16x

GTBP2.51x

Debt/Equity (TTM)

ACTU0.41x

GTBP0.00x

Debt/Assets (TTM)

ACTU0.0%

GTBP0.0%

Interest Coverage (TTM)

ACTUN/A

GTBPN/A

Net Debt/EBITDA (TTM)

ACTU0.00x

GTBP0.00x

Beta

ACTU1.66

GTBP0.81

52W Performance

ACTU-91.3%

GTBP-75.3%

YTD Performance

ACTU-89.9%

GTBP-67.3%

% from 52W High

ACTU-92.8%

GTBP-76.8%

% from 52W Low

ACTU1.0%

GTBP36.0%

Asset Turnover (TTM)

ACTU0.00x

GTBP0.08x

FCF Yield (TTM)

ACTU-135.8%

GTBP-4.9%

Earnings Yield (TTM)

ACTU-140.1%

GTBP-11.1%

Dividend Yield (TTM)

ACTUN/A

GTBPN/A

Rule of 40

ACTU0.0

GTBP0.0

EV/GP/RG

ACTUN/A

GTBPN/A

Ticker research

View ACTU research View GTBP research

Metric	ACTU Actuate Therapeutics Inc	GTBP GT Biopharma Inc
Market & Valuation
Market Cap	$15M	$296M
Enterprise Value	$11M	$291M
Price	$0.61	$6.68
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	174.71x
EV/Sales	0.00x	95.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.88x	3.08x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.53x	-20.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	50.1%	216.5%
Profitability
Gross Margin (TTM)	0.0%	36.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-20M	$-33M
FCF (TTM)	$-20M	$-14M
EPS (TTM)	-$0.86	-$21.10
ROE (TTM)	-34618.0%	-44308.0%
ROA (TTM)	-17840.0%	-31311.0%
ROIC (TTM)	-32397.0%	-44308.0%
Financial Health
Cash	$4M	$5M
Debt	$405K	$0
Net Cash/Debt	$4M	$5M
Current Ratio (TTM)	1.25x	2.61x
Quick Ratio (TTM)	1.16x	2.51x
Debt/Equity (TTM)	0.41x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	0.81
52W Performance	-91.3%	-75.3%
YTD Performance	-89.9%	-67.3%
% from 52W High	-92.8%	-76.8%
% from 52W Low	1.0%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.08x
FCF Yield (TTM)	-135.8%	-4.9%
Earnings Yield (TTM)	-140.1%	-11.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACTU research	View GTBP research